Skip to main content
Decorative image of the Sepsis Learning Lounge

Sepsis And Opioid Use Disorder: The Intersection Of Two Public Health Crises

SUMMARY

Sepsis and opioid use disorders are major sources of morbidity, mortality, and costs to the healthcare system. While most of the national focus has been on the rising number of fatal opioid overdoses, less attention has been paid to the serious infectious complications of opioid use disorders, including sepsis.  In this presentation, Drs. Rhee and Kimmel will review recent data elucidating the epidemiology of sepsis and opioid-related hospitalizations and discuss potential strategies for reducing the harms associated with the intersection of these two public health emergencies.

FEATURED EXPERT    

Chanu Rhee, MD, MPH, FIDSA, Assistant Professor of Population Medicine, Harvard Pilgrim Health Care Institute / Harvard Medical School

Simeon Kimmel, MD, MA, Assistant Professor of Medicine, Boston University School of Medicine and Boston Medical Center


REGISTER FOR THE WEBINAR

Two experts share their review of recent data elucidating the epidemiology of sepsis and opioid-related hospitalizations.


We want to hear from you!

Your feedback helps us continue to provide resources and content specific to your needs.


U.S. bioMérieux Solutions

US Solutions

VIDAS® B•R•A•H•M•S PCT™

Detects procalcitonin, a biomarker that aids in the risk assessment for progression to severe sepsis and septic shock. PCT also aids in decision making on antibiotic therapy for patients with lower respiratory tract infections (LRTI).

PUBLISHED BY

Sepsis Alliance
January 4, 2022


SHARE THIS ARTICLE: